BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4+ Th1 responses. - Rollin P; Pluskwa B; Artru E; Le Vaslot T; Kartasheva-Ebertz D; Biron D; Bossis M; Onodi F; LeMaoult J; Rouas-Freiss N; Chevalier MF; Lindestam Arlehamn CS; et al. (IScience, 2026)